Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma

International Journal of Cancer

Volumn 123, Issue 4, 2008, Pages 826-830

  Yan, Ru Qin ^a   Fu, Li ^b   Sham, Pak C ^b   Kwong, Dora L W ^b   Cai, Lei Zhu ^b   Chu, Kevin K W ^b   Li, Yan ^c   Guan, Xin Yuan ^b,c  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Deletion; Esophageal carcinoma; Loss of heterozygosity; Tumor suppressor gene

Indexed keywords

ANALYTIC METHOD; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CHROMOSOME 3P; CHROMOSOME DELETION; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENE DELETION; GENE EXPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INCIDENCE; METASTASIS; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM MASS ARRAY; BIOSYNTHESIS; CHROMOSOME 3; ESOPHAGUS TUMOR; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

MESSENGER RNA;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; ESOPHAGEAL NEOPLASMS; GENES, TUMOR SUPPRESSOR; HUMANS; LOSS OF HETEROZYGOSITY; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 47049116137     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23577     Document Type: Article

References (29)

1. Parkin DM, Prsani P, Ferley J. Estimation of the world-wide incidence of eighteen major cancers in 1985. Int J Cancer 1993;54:594-606.
2. Yang CS. Research on esophageal cancer in China: a review. Cancer Res 1980;40:2633-44.
3. Li JY. Epidemiology of esophageal cancer in China. Natl Cancer Inst Monogr 1982;162:113-20.
4. Day NE, Varghese C. Oesophageal cancer. Cancer Surv 1994;19/20:43-54.
5. Pack SD, Karkera JD, Zhuang Z, Pak ED, Balan KV, Hwu P, Park WS, Pham T, Ault DO, Glaser M, Liotta L, Detera-Wadleigh SD, et al. Molecular cytogenetic fingerprinting of esophageal squamous cell carcinoma by comparative genomic hybridization reveals a consistent pattern of chromosomal alterations. Genes Chromosomes Cancer 1999;25:160-8.
6. Yen CC, Chen YJ, Chen JT, Hsia JY, Chen PM, Liu JH, Fan FS, Chiou TJ, Wang WS, Lin CH. Comparative genomic hybridization of esophageal squamous cell carcinoma: correlations between chromosomal aberrations and disease progression/prognosis. Cancer 2001;92:2769-77.
7. Kwong D, Lam A, Guan X, Law S, Tai A, Wong J, Sham J. Chromosomal aberrations in esophageal squamous cell carcinoma among Chinese: gain of 12p predicts poor prognosis after surgery. Hum Pathol 2004;35:309-16.
8. Ogasawara S, Maesawa C, Tamura G, Satodate R. Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 1995;55:891-4.
9. Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, et al. Identification of novel regions of allelic loss from a genomewide scan of esophageal squamous-cell carcinoma in a high-risk Chinese population. Genes Chromosomes Cancer 2000;27:217-28.
10. Tai AL, Yan WS, Fang Y, Xie D, Sham JS, Guan XY. Recurrent chromosomal imbalances in nonsmall cell lung carcinoma: the association between Iq amplification and tumor recurrence. Cancer 2004;100:1918-27.
11. Fang Y, Guan XY, Guo Y, Sham J, Deng M, Liang Q, Li H, Zhang H, Zhou H, Trent J. Analysis of genetic alterations in primary nasopharyngeal carcinoma by comparative genomic hybridization. Genes Chromosomes Cancer 2001;30:254-60.
12. Hurst CD, Fiegler H, Carr P, Williams S, Carter NP, Knowles MA. High-resolution analysis of genomic copy number alterations in bladder cancer by microarray-based comparative genomic hybridization. Oncogene 2004;23:2250-63.
13. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-20.
14. de Thé H, Vivanco- Ruiz M, Tiollais P, Stunnenberg H, Dejean A. Identification of retinoic responsive element in the retinoic acid receptor gene. Nature 1990;343:177-80.
15. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM, Huebner K. The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell 1996;84:587-97.
16. Dammann R, Li C, Yoon JH, Chin PL, Bates S, Pfeifer GP. Epigenetic inactivation of a RAS association domain family protein from the lung tumor suppressor locus 3p21.3. Nat Genet 2000;25:315-9.
17. Ji L, Nishizaki M, Gao B, Burbee D, Kondo M, Kamibayashi C, Xu K, Yen N, Atkinson EN, Fang B, Lerman MI, Roth JA, et al. Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Res 2002;62:2715-20.
18. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 1999;59:1966-72.
19. Kuroki T, Trapasso F, Yendamuri S, Matsuyama A, Alder H, Mori M, Croce CM. Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res. 2003;63:3724-8.
20. Tai AL, Mak W, Ng PK, Chua DT, Ng MY, Fu L, Chu KK, Fang Y, Song YQ, Chen M, Zhang M, Sham PC, et al. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Res 2006;66:4133-8.
21. Sobin LH, Wittekind C, eds. TNM classification of malignant tumors, 5th edn. New York: Wiley, 1997. 227 p.
22. Shimada Y, Imamura M, Wagata T, Yamaguchi N, Tobe T. Characterization of 21 newly established esophageal cancer cell lines. Cancer 1992;69:277-84.
23. Rokman A, Baffoe-Bonnie AB, Gillanders E, Fredriksson H, Autio V, Ikonen T, Gibbs KD Jr, Jones M, Gildea D, Freas-Lutz D, Markey C, Matikainen MP, et al. Hereditary prostate cancer in Finland: fine-mapping validates 3p26 as a major predisposition locus. Hum Genet 2005;116:43-50.
24. Yang XJ, Oqryzko VV, Nishikawa J, Howard BH, Nakatani Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature 1996; 382:319-24.
25. Penkov D, Ni RJ, Else C, Pinol-Roma S, Ramirez F, Tanaka S. Cloning of a human gene closely related to the genes coding for the c-myc single-strand binding proteins. Gene 2000;243:27-36.
26. Nakamura Y, Fukami K, Yu HY, Takenaka K, Kataoka Y, Shirakata Y, Nishikawa S, Hashimoto K, Yoshida N, Takenawa T. Phospholipase Cd1 is required for skin stem cell lineage commitment. EMBO J 2003;22:2981-91.
27. Fu L, Qin YR, Xie D, Hu L, Kwong DL, Sirvastava G, Tsao SW, Guan XY. Characterization of a novel tumor suppressor gene Phospholipase C-δ1 at frequently deleted region 3p22 in esophageal squamous cell carcinoma. Cancer Res 2007;67:10720-6.
28. Carboni GL, Gao B, Nishizaki M, Xu K, Minna JD, Roth JA, Ji L. CACNA2D2-mediated apoptosis in NSCLC cells is associated with alterations of the intracellular calcium signaling and disruption of mitochondria membrane integrity. Oncogene 2003;22:615-26.
29. Shimada Y, Sato F, Watanabe G, Yamasaki S, Kato M, Maeda M, Imamura M. Loss of fragile histidine triad gene expression is associated with progression of esophageal squamous cell carcinoma, but not with the patient's prognosis and smoking history. Cancer 2000;89:5-11.